Enhanced Dynamic Wedge Implementation Guide
Enhanced Dynamic Wedge Implementation Guide
P/N 1103580-02
January 2002
Abstract The C-Series Clinac, Enhanced Dynamic Wedge Implementation Guide (P/N 1103580-02)
provides information about how to use and measure enhanced dynamic wedges.
Technical If you cannot find information in this user guide, you can contact us in several ways:
Support ■ United States telephone numbers:
Support 1-800-535-5350
To order additional documents 1-800-535-5350 (press 2)
Fax-on-Demand 1-800-278-2747 (press 4)
■ International telephone numbers:
Fax +1-408-321-4344
Support—Europe, South America +1-408-321-4474
Support—Far East, Pacific Rim +1-408-321-4475
■ United States mail:
Varian Medical Systems, Inc. +1-650-424-6567
3100 Hansen Way, Bldg. 4A
Palo Alto, CA 94304-1030, U.S.A.
■ European representative:
Varian Medical Systems, UK Ltd. Phone: +44-1293-531-244
Gatwick Road, Crawley Fax: +44-1293-510-260
West Sussex, RH102RG, England
If you have access to the World Wide Web, you can find Varian Customer Services at
http://www.varian.com. Click Oncology Systems and then Support.
Notice Information in this user guide is subject to change without notice and does not represent a
commitment on the part of Varian. Varian is not liable for errors contained in this guide or for
incidental or consequential damages in connection with furnishing or use of this material.
ISO 9000 / Varian Medical Systems, Oncology Systems products are designed and manufactured in
EN 46000 accordance with the requirements specified within ISO 9001 and EN 46001 quality standards.
Series
CE Varian Medical Systems, Oncology Systems products meet the requirements of Council
Directive MDD 93/42/EEC.
Trademarks Clinac is a registered trademark and PortalVision and Enhanced Dynamic Wedge are
trademarks of Varian Medical Systems, Inc. Microsoft and Windows are registered trademarks
of Microsoft Corporation.
© 1996–2002 Varian Medical Systems, Inc.
All rights reserved. Printed in the United States of America.
ii
CHAPTER SUMMARY
Introduction 1
Historical Perspective 2
Measurement Techniques 5
Clinical Operation 6
Quality Assurance 7
STT Computations B
Glossary D
Index Index
iii
Contents
PREFACE............................................................................................................ V
Who Should Read This Guide....................................................................... v
Visual Cues ................................................................................................... v
Related Publications .................................................................................... vi
How This Guide Is Organized ..................................................................... vii
v
Description of Segmented Treatment Tables............................................. 3-7
Specifics About the Sample STT....................................................... 3-9
STT as a Dose Versus Jaw Position Function ................................ 3-10
Continuous Dose Delivery or Jaw Motion Model............................. 3-11
More About the Sample STT........................................................... 3-11
STT Generation and Delivery................................................................... 3-12
STT Generation............................................................................... 3-12
STT Delivery.................................................................................... 3-19
Tracking Accuracy Statistics for Dose and Jaw Position ......................... 3-21
Dynalog Files ........................................................................................... 3-23
Date and Time Stamp ..................................................................... 3-27
Treatment Setup.............................................................................. 3-27
Dynamic Beam Statistics................................................................. 3-27
Total Dose Delivered....................................................................... 3-27
Dose Standard Deviation ................................................................ 3-27
Dose Position Standard Deviation................................................... 3-28
Number of Samples......................................................................... 3-28
Segment Boundary Samples........................................................... 3-29
vi
Surface Dose ........................................................................................... 4-23
EDW Surface Dose ......................................................................... 4-23
Physical Wedge Surface Dose........................................................ 4-23
Peripheral Dose ....................................................................................... 4-24
EDW Data in Treatment Planning ............................................................ 4-25
Tabulated Data Sets........................................................................ 4-25
Generated Data Sets....................................................................... 4-26
vii
CHAPTER 7 QUALITY ASSURANCE ......................................................... 7-1
Dynamic Wedge QA Programs .................................................................. 7-2
Assigned Responsibility .................................................................... 7-2
Baseline Standards ........................................................................... 7-3
Plan Simple and Rapid Measurement Techniques ........................... 7-3
Daily Tests......................................................................................... 7-3
Monthly Tests .................................................................................... 7-4
Recommendations ............................................................................ 7-4
Dynamic Wedge Quality Assurance Programs ................................. 7-5
Densitometry or Single Probe Measurements................................... 7-6
Acceptance Testing.................................................................................... 7-7
Initial Measurement ........................................................................... 7-7
Treatment Planning Checks .............................................................. 7-9
Routine Machine Checks ................................................................ 7-10
Checks Specific to Each Treatment ................................................ 7-11
Evolving Technology ................................................................................ 7-12
viii
Preface
The purpose of this guide is to assist you with implementation of the Enhanced
Dynamic Wedge (EDW) feature. The information in this guide includes
definitions, measurement techniques, and comparative data. All data sets
included in this guide are representative only. Actual machine-specific data
acquisition is the responsibility of the physicist because there are nominal
variations from machine to machine.
Visual Cues
This guide uses the following visual cues to help you locate and identify
information:
Italic text is used for emphasis and book titles.
Bold text identifies menu commands, items you can click or select on the
screen, and keyboard keys.
Monotype font identifies file names, folder names, and text that either
appears on the screen or that you are required to type in.
Note: Describes actions or conditions that can help the user obtain
optimum performance from the equipment or software.
v
Related Publications
vii
Chapter 1 Introduction
Enhanced Dynamic Wedge is a Clinac treatment that you can use modality to
deliver wedge-shaped photon dose distributions using computer-controlled
dose delivery combined with upper jaw motion.
In This Chapter
Topic Page
Introduction to Enhanced Dynamic Wedge 1-1
General Capabilities 1-4
Additional Features 1-6
The Enhanced Dynamic Wedge (EDW) technique differs from the physical
(metal) wedge technique in that no external beam modifier is used to create the
wedged dose profile. Instead, the wedged isodose profile is created by the
sweeping action of the jaw from open to closed position while the beam is on
(see Figure 1-1).
1-1
Figure 1-1 Jaw Sweeping Action
Throughout the treatment, dose is delivered and the jaw is moved under
computer control. The relationship between dose delivered and jaw position is
well-defined within the control system and is accurately followed in order to
create the wedge-shaped field of the desired wedge angle. Computer control
ensures that dose delivered versus jaw position follows the exact precalculated
pattern that produces the prescribed dose distribution.
In general, all EDW treatments start with some portion of the dose being
delivered as an open field (a portion of the total dose is delivered before the jaw
starts moving). After the appropriate fraction of total dose has been delivered,
the jaw starts sweeping the field from open to closed position. The exact
fraction of dose that is delivered as an open field is a function of the selected
energy, field size, and wedge angle. Similarly, the exact relationship between
dose delivered and jaw position during the sweep portion of the treatment is
also a function of selected treatment energy, field size, and wedge angle.
The number of monitor units delivered as the jaw sweeps the field is
continuously adjusted to achieve the desired dose distribution.
The dose rate and jaw speed are also varied during the treatment. This allows
the treatment to be delivered in the shortest possible time.
Introduction 1-3
General Capabilities
Wedge Angles 15°, 30°, 45°, 10°, 15°, 20°, 25°, 30°,
60° 45°, 60°
Introduction 1-5
Additional Features
The following additional features are included with the Enhanced Dynamic
Wedge:
■ Lower peripheral dose outside the treatment field compared to metal
wedges, resulting in lower dose to adjacent sensitive structures.
■ Elimination of beam hardening (as is common with physical wedges), so
that the delivered dose corresponds more closely to the planned dose.
■ STTs that define large (30 cm) field fluence distributions, analogous to
physical wedges. STTs are automatically truncated to the desired field
size, a process that is dosimetrically similar to the use of physical wedges.
■ Treatment times that are comparable to, or in most common clinical cases,
faster than physical wedges.
■ Wedges that are selected with the push of a button. The elimination of
physical wedges allows the operator more opportunity to focus on the
patient, and reduced setup time between fields for the same patient and in
between patients.
■ Use of EDW in conjunction with a multileaf collimator (MLC) and Auto
Field Sequency (AFS) makes it possible to automatically shape and
modulate a set of fields from outside the treatment room.
■ Two wedge orientations, Y1-IN and Y2-OUT, reducing the need for
time-consuming collimator rotation.
■ Unobstructed light field allowing the exact treatment area to be viewed
during setup.
■ Use of a multiple asynchronous parallel processor (MAPP) computer that
can automatically resume treatment at the exact point of interruption when
partial treatments are necessary. The remaining monitor units is the only
extra parameter that must be input into the system to perform a partial
treatment.
■ Incorporation of morning checkout, an embedded quality assurance tool,
allowing easy verification of Dynamic Wedge operation.
■ Availability of several data sources for treatment planning: STTs, detector
arrays, or film.
Introduction 1-7
Chapter 2 Historical Perspective
This chapter describes the historical perspective of the dynamic wedge and
some of the differences among Enhanced Dynamic Wedge, dynamic wedge,
and physical wedges. For the full list of references, see Appendix C.
In This Chapter
Topic Page
Research and Implementation 2-1
Wedge Angle Definition 2-2
For many years, a “poor man’s wedge” has been generated by manually
moving a lead block to successive positions across an open treatment field. The
technical literature has also contained reports on the use of
computer-controlled jaw motion to produce wedge-shaped isodose
distributions since 1978 (Ref 1). This particular effort demonstrated proof of
concept, but it was not practical to implement for routine treatments because
computer control was not commercially integrated with the accelerator.
In early 1990, D. Leavitt published a paper that confirmed the earlier published
work (Ref. 2). The major difference in this latter case was that the computer
was commercially integrated with the accelerator control (C-Series). This
made it practical to implement for routine clinical treatments. Each photon
energy required 132 Segmented Treatment Tables (STTs), one for each field
size and wedge angle combination.
2-1
First Clinical Implementation
In 1991, Varian introduced Dynamic Wedge, the first clinical implementation
of this feature. The foundation for this feature was D. Leavitt’s work. This
early implementation was limited to four wedge angles and symmetric fields.
The nominal wedge angle is defined as the angle through which the 80%
isodose contour has been turned at the central axis. The 80% isodose contour
varies in depth between 5 and 10 cm, depending on the X-ray energy. Because
the isodose contours of a physical wedge are curved, this is generally
interpreted to mean the tangent to the isodose contour at central axis.
The present physical wedges are optimized to produce the desired nominal
wedge angle at the largest field size that the wedge covers (20 cm for the 15°,
30°, and 45° wedges and 15 cm for the 60° wedges).
In This Chapter
Topic Page
Combined Continuous Dose Delivery And Jaw Motion 3-2
STT Based 3-2
Selected Dose Rate Acts as a Dose Rate Ceiling 3-5
Beam’s Eye View Collimator Graphic 3-5
Dose Delivered and Jaw Speed Modulation 3-6
Description of Segmented Treatment Tables 3-7
STT Generation and Delivery 3-12
Tracking Accuracy Statistics for Dose and Jaw Position 3-21
Dynalog Files 3-23
3-1
Combined Continuous Dose Delivery And Jaw
Motion
In general, the control system delivers an EDW treatment by moving one of the
two upper jaws while the beam is on. Both dose rate and jaw speed are
modulated according to a precise, precalculated pattern. It is this combination
of dose delivery while the jaw sweeps the field that creates the
operator-selected wedged isodose profile.
STT Based
The dose versus jaw position relationship that is followed during an EDW
treatment is contained in a dose versus position table referred to as Segmented
Treatment Table (STT). STTs are discussed in more detail in Appendix A. The
dose versus jaw position relationship uniquely determines the dose profile.
EDW treatments consist of two phases: an open field phase and a jaw sweep
phase.
During the open field phase of the treatment, the dose rate is constant and
equals the dose rate selected by the operator for the treatment. The jaws remain
fixed during this phase.
After the open field phase of the dose has been delivered, the jaw starts
moving, usually at its maximum speed, while dose rate is reduced. As the
sweep progresses, the jaw speed is typically reduced and the dose rate
gradually increases, but never exceeds the selected dose rate. Figure 3-1 and
Figure 3-2 show example progressions of dose rate and jaw speed during an
EDW treatment. Figure 3-3 shows the dose versus jaw position relationship.
In general, the exact progression of dose rate and jaw speed, as well as the
phase of the total dose that is delivered as an open field, depends on the wedge
angle, field size, total monitor units, and beam energy that were selected by the
operator. Therefore, for a given wedge angle, the field size, monitor units, and
beam energy, the progression of dose rate and jaw speed, and consequently, the
dose versus jaw position function, are completely determined and thus always
follow the same precalculated pattern (see Figure 3-3).
Because of the dose rate modulation, the operator selected dose rate should not
be viewed as an absolute dose rate, but rather as a maximum dose rate or dose
rate ceiling for the EDW treatment.
While the control system is in EDW mode, a beam’s eye view graphic of the
collimator opening is continuously displayed on the control system monitor
(see Figure 6-2 through Figure 6-6). This is a real-time graphic which is
updated several times a second. The sweeping action of the jaw that takes place
during an EDW treatment can be seen on the beam’s eye view collimator
graphic.
Note: The beam’s eye view collimator graphic shows only the
collimator opening. It does not show collimator rotation.
During an EDW treatment, dose delivery and jaw motion are continuous,
although jaw speed and dose rate changes according to a precalculated pattern.
The control system calculates the dose rate and jaw speed to be used at each
point in the treatment before the treatment starts. As a result, dose rate and jaw
speed always follow the same pattern for the same EDW setup (that is, for the
same beam energy, monitor units, field size, and wedge angle).
Within the control system, each EDW treatment is associated with an STT. The
STT describes the dose versus jaw position relationship to be followed during
the EDW treatment in order to produce the operator-selected wedged beam
profile. The control system computes the STT after all the relevant EDW
parameters (energy, orientation, field size, and angle) have been specified by
the operator.
While the STT specifies dose and position only at discrete points, the control
system enforces a linear progression of dose and position from one STT row to
the next.
All EDW STTs are generated with 20 segments, regardless of field size. Given
the continuous method of beam delivery with motion, this is more than
adequate to specify a precise dose versus jaw position path. In effect, STT rows
are needed only to describe inflection points, that is, slope changes in the EDW
dose versus position function.
The slope of each line segment determines the dose rate and jaw speed to be
used for the segment. For each segment, the dose rate and jaw speed are
calculated so that either the dose rate or jaw speed are at maximum. This results
in the shortest possible treatment time. For a particular dose to the target
volume, the treatment time for EDW is, in most cases, shorter than the time
required to deliver the same dose using a physical wedge.
The user interface for the EDW option is similar to the interface for the
physical wedge option. If the option is enabled, the correct orientation of the
wedge field must be confirmed inside the treatment room using the hand
pendant before treatment can be given. Pretreatment verification sequences
occur as with other treatments.
Dose delivery commences with the open field segment and ends with the jaws
closed. The jaws remain in this generally asymmetric field position until reset
by the operator, thereby allowing another visual verification of jaw closure.
1. Generation of the STT that applies to a specific EDW setup (see “STT
Generation” on page 3-12).
2. Delivery of the generated STT (see “STT Delivery” on page 3-19).
STT Generation
In the STT generation step, the EDW parameters entered by the operator on the
Clinac console are converted into an STT. The STT generation begins when
the operator finishes entering all the relevant treatment parameters.
The progression of dose rates and jaw speeds to be used during beam-on are
also calculated at this point, that is, before beam-on.
1. Read fluence for selected energy from disk (“Step 1: Fluence Profiles” on
page 3-14).
2. Derive fluence for selected effective wedge angle (“Step 2: Computation
of Effective Wedge Angles” on page 3-15).
3. Truncate fluence to selected field size (“Step 3: Truncation Process” on
page 3-18).
4. Normalize fluence to total dose (“Step 4: Normalize” on page 3-19).
5. Compute dose rate and jaw speeds for all segments (“Step 5: Compute” on
page 3-19).
EDW beam fluence for the selected energy is read from the hard disk. EDW
uses one predefined fluence profile data set for each photon beam energy.
These fluence profiles are stored in files on the Clinac computer hard disk. One
fluence profile is used for high energy, the other for low energy. These fluence
profiles are also referred to as Golden STTs.
Each profile describes the dose fluence required to deliver a full field 60°
EDW. Full field is the 30 cm wide, asymmetric field from 20 cm to -10 cm.
These base fluences are used to numerically derive STTs for any wedge angle
and field size. This method is simpler than dynamic wedge, where separate
fluence profiles were stored on disk for every combination of field size and
wedge angle.
The 60° fluence profile is combined with open field dose to derive the fluence
profile that corresponds to the effective wedge angle.
Two weights, W0° and W60°, are computed based on the effective wedge angle
θ:
tan θ
W 60° = -----------------
tan 60°
The effective angle fluence is then computed as the weighted average of the
dose in the 0° and 60° fluences. The following linear combination formula is
used:
The effective angle fluence is truncated to the actual field size used in the
specific treatment. Figure 3-8 depicts this truncation process. In this figure, P1
and P2 correspond to the actual field size, as specified by the operator by
means of the COLL Y1 and COLL Y2 EDW parameters.
The truncated dose fluence is normalized to yield the STT specific to the
treatment setup. Normalization is done by proportionally scaling the dose so
that the final dose (dose at P2 in Figure 3-8) is the total dose (MU value)
programmed by the Clinac operator. The treatment-specific STT is completely
defined at the end of this step.
Step 5: Compute
After the STT has been normalized, the dose rate and jaw speed to be used for
each segment of the EDW treatment are calculated.
STT Delivery
STT delivery begins when the operator presses the BEAM ON button. The
control system turns the beam on and starts to follow the dose rate versus jaw
position path specified by the STT.
Dose rated jaw speeds start following the precalculated pattern that was
calculated in the STT generation step.
When the STT for an EDW treatment is computed, it becomes the dose versus
position path that the control system is committed to follow during the
treatment. The control system measures and verifies the delivery, and suspends
or stops treatment if the actual delivery does not follow the STT plan.
Because an EDW treatment first delivers the open field portion of the dose, the
treatment must start with the actual jaw positions matching COLL Y1 and
COLL Y2.
An Initial Position Interlock (IPSN) ensures that treatment does not start until
the jaws are placed at their proper starting positions. The IPSN interlock is
cleared when the jaw positions are within 0.1 cm of the COLL Y1 and COLL
Y2 values.
The control system maintains the dose versus position relationship during the
treatment by varying the dose rate and the motor speed from maximum to zero.
The control system compares the actual positions of the jaws to the intended
positions 20 times per second. A jaw is in the hot window when it is within 0.15
cm of its intended position. If a jaw moves out of this window, the control
system suspends the beam while trying to recover the jaw position.
A cold window, when the beam is off and the jaws are more than 0.15 cm and
less than 0.5 cm outside their intended positions, allows the jaw 3 seconds to
regain its position before the treatment is interrupted by an interlock. When the
jaws are again in the hot window, the control system resumes the beam and the
STT segment from the point treatment was suspended.
DPSN Interlock
The Dynamic Position Interlock (DPSN) terminates the treatment if the dose
versus position relationship implied by the STT is not accurately followed.
The control system gathers dose and position accuracy statistics for each EDW
treatment. The statistics are displayed to the operator and logged to disk files
at the end of every clinical EDW treatment.
The control system tracks the actual dose and position throughout the EDW
treatment in real time. Samples of the data and any deviations from the plan are
logged at regular intervals. Typically, hundreds of samples are taken
throughout an EDW treatment. The actual number of samples is proportional
to treatment duration.
At the end of the treatment, standard deviations for the dose and the
dose-weighted position are computed and displayed to the operator in the
Treatment Complete message.
Dose weighting of the position deviation reflects the fact that position
deviations are irrelevant unless dose is being delivered.
The two standard deviations are also logged onto the control system hard disk.
These two statistics are the most informative representation of how closely a
specific EDW treatment followed the STT specified dose and position path.
i=N 2
Σ i = 1 ( ( D i, act – D i – 1 ,act ) ( P i, plan – P i ,act ) )
σ DP = ---------------------------------------------------------------------------------------------------------------
-
D
Variable Meaning
Note: ■ The control system and its interlocks guarantee the accurate
delivery of an EDW treatment. The Clinac operator need
not be concerned with dynalog files. Dynalog files are just
records containing more detailed information about the
EDW treatment performed.
■ This sample dynalog is included for illustration only. The
actual dose and jaw position values are not of any
significance.
DATE......................: 06/23/2001
TIME......................: 10:58:23
**TREATMENT SETUP
ENERGY : 6X
MU : 300
ORIENTATION : Y1-IN
WEDGE ANGLE : 45
Treatment Setup
Treatment setup information is essentially a duplicate of the treatment setup
information displayed in the treatment summary box of the Clinac console
screen at the time of the treatment. This section lists the treatment setup
parameters selected by the operator, that is, treatment type, beam energy, dose,
wedge orientation, field size, wedge angle, time, and accessory (if any).
Number of Samples
The number of samples is the total number of samples (snapshots) upon which
the two standard deviation values are based.
The STT area lists the treatment-specific STT that was generated and used for
the particular EDW treatment (see “STT Generation” on page 3-12).
Dynalog files are stored on the Clinac computer hard disk under the directory
C:\VARIAN\DYNALOG. Dynalog files for the most recent 199 EDW and arc
treatments are stored. After 199 dynalog files have been logged, every new
dynalog file overwrites the oldest dynalog file.
In This Chapter
Topic Page
Data Handling Techniques 4-2
EDW Compared to Physical Wedges 4-2
Effective Wedge Factor 4-17
Depth Dose 4-21
Surface Dose 4-23
Peripheral Dose 4-24
EDW Data in Treatment Planning 4-25
4-1
Data Handling Techniques
Wedge Distribution
EDW STTs are designed to deliver the prescribed wedge angle over as large a
fraction of the field as possible. In contrast, the physical wedge angle is defined
by the attenuation through the physical wedge.
Isodose Curves
The side-by-side comparison of isodose curves in Figure 4-1 through
Figure 4-4, Figure 4-5 through Figure 4-8, Figure 4-9 through Figure 4-12,
and Figure 4-13 through Figure 4-15 demonstrate the major differences
between EDW and physical wedge distributions. The figures show wedge
angles of 15°, 30°, 45°, and 60°, respectively. The physical wedge is to the left
and the EDW is to the right in each comparison. Isodoses are adjusted to 100
percent at 10 cm depth on central axis.
Figure 4-10 Comparison of 30° Physical Wedge and EDW (15 cm Wide Field)
Figure 4-12 Comparison of 60° Physical Wedge and EDW (15 cm Wide Field)
Figure 4-14 Comparison of 30° Physical Wedge and EDW (20 cm Wide Field)
The greatest differences are shown in the larger field sizes and wedge angles,
where the defined isodose line covers a greater fraction of the field. For the
smaller fields, the shape of the isodose lines are more alike. This effect has
been achieved by allowing some convexity into the isodose shape, rather than
forcing the isodose line to maintain the wedge angle to the extreme of the field.
Effective wedge factor for EDW is defined as the ratio of the ion chamber
integrated reading at a depth of 10 cm on the central axis, compared to the
integrated reading for open field for the same number of monitor units. In
EDW, this ratio changes drastically with field width and wedge angle.
Figure 4-16 illustrates the effective wedge factor versus field size and wedge
angle for fields to 20 cm wide.
As you can see, the wedge factor is a smooth and continuous function of field
size.
Physical Wedges
The Varian physical wedges used to modify radiation field dose distributions
lock into position in the accessory tray of the Varian linear accelerators such
that the central axis of the photon beam always intersects the same point on the
wedge.
The ratio of ion chamber readings at 10 cm depth on central axis with wedge
in field versus open field was measured for 45° and 60° wedges for 6 MV
photons.
The ratio of the wedge factors for the largest field to the smallest field were
1.012 for the 45° wedge and 1.008 for the 60° wedge, indicating the small
variation in wedge factor with field size for the Varian physical wedges.
Note: One simple rule of thumb for estimating the effective wedge
factor for EDW fields is to divide the total number of monitor
units delivered at the time that the moving jaw crosses the
central axis by the total number of monitor units delivered at the
completion of treatment.
This section describes the depth dose factors as they relate to EDW and
physical wedges.
Careful measurement of depth doses for open field and EDW show agreement
to within 2% for depths from dmax to 30 cm for nearly every field. For example,
measurements in a phantom for a 20 cm by 20 cm 60° EDW indicate a
progressive increase with depth in the ratio of central axis dose in the wedge
field compared to the open, nonwedged field.
This section discusses the surface dose of EDW and physical wedges.
Surface dose and dose in the build-up region for 6 MV was measured using
integrated ionization readings from an energy-compensated diode and repeated
using a parallel plate ion chamber. These readings showed increases in the
surface dose for EDW relative to open field ranging from less than 1% for the
small fields and small wedge angles to approximately 2% for the largest field
and wedge angle.
Peripheral doses for EDW are reduced by a factor of two compared to the
corresponding values for physical wedge fields (Figure 4-18).
Figure 4-18 Ratio of Dose Outside Field Edge to Central Axis Dose
The peripheral dose for physical wedge fields is higher due to the scatter out of
the field generated by the interactions of the primary photon beam with the
physical wedge.
The peripheral doses for EDW are only slightly higher than those for the
corresponding open field. This is a clinical advantage for EDW; for example,
the minimization of dose to the contra lateral breast is a prime concern in
radiation treatment of breast cancer.
Some treatment planning systems are limited to one wedge factor per wedge
angle. For these systems, implementation of the EDW factor, which varies
with both field width and wedge angle, may pose a problem. Until this
limitation can be overcome within these systems, a manual correction to the
wedge factor output may be required. You should work closely with the
treatment planning computer vendor to resolve this problem.
The ideas in this section are suggested to help you get started using EDW for
treatment planning. Before using EDW for treatment planning, you are
encouraged to discuss the techniques most suitable for your system with the
treatment planning system vendor.
Treatment planning data sets can be divided into two general groups:
■ Tabulated
■ Generated
Systems requiring tabulated data generally require a few dose profiles for each
field size and wedge angle. These profiles are acquired using a water phantom
dosimetry system. The profiles can usually be fed directly into the treatment
planning system. The same technique can be applied to EDW. Dose
measurements should be made using a linear detector array of diodes or ion
chambers in a water phantom (“Linear Detector Arrays” on page 5-14) or
through film densitometry (“Film Densitometry” on page 5-7).
Implementation of generated data may take many forms. Klein (Ref. 7) created
an effective wedge for each wedge angle, and then generated the required
fields using the physical wedge generator program resident in their treatment
planning systems.
The primary intensity profile for the widest EDW can be measured for each
wedge angle. Typically, this measurement is made at a depth of dose build-up,
dmax.
These primary intensity profiles are then used as a primary wedge profile.
The specific profiles for narrower wedges are then created by multiplying the
primary wedge profile by an edge function that defines the penumbra and
includes the transmission through the jaws.
Using STTs
Boyer (Ref. 8) has converted the table of integral monitor units delivered into
an intensity table by factoring the output factor versus field size into the
monitor unit table, then applying this intensity function to the open field dose
distribution to create the EDW dose distribution. This method appears to work
well as a technique to modify existing open field data to predict EDW field
data.
Leavitt has used the STTs to calculate the EDW dose distribution as the
summation of a series of asymmetric fields weighted according to the monitor
unit values in the STTs and corrected for the relative change in output per
monitor unit versus field size. This summated field distribution can then be
used directly in treatment planning. This same technique can be applied to
treatment planning systems using pencil beam dose calculation algorithms.
This chapter covers measurement techniques that you can use to:
■ Verify jaw motions, field size definitions, and wedge field shapes
■ Measure the data required for computerized or manual treatment planning
In This Chapter
Topic Page
Collimator Field Size Check 5-1
Measurement Devices 5-3
Depth Dose Measurements 5-4
Effective Wedge Factor Measurements 5-6
Beam Profile Measurements 5-6
5-1
To verify field sizes, position one movable jaw in a fixed location, then move
the second independent jaw to a series of asymmetric settings and measure the
width of the X-ray field. The agreement should be to within 1 mm across the
entire range of measurements. Typically, radiographic verification film is used
to perform this X-ray field size check.
In addition, you should verify the coincidence of the crosshairs with the center
of the field. An offset error in the location of the crosshairs introduces small
errors in all positional measurements conducted for dynamic wedge.
For systems that require effective wedge filter transmission factors you can
determine beam profile measurements from measured dynamic wedge profile
data.
Ionization Chambers
Both parallel-plate and cylindrical ionization chambers are commonly used in
radiation therapy measurements.
Diodes
Energy-compensated diodes are similar in energy response to ionization
chambers, but offer a smaller measurement cross section and thinner depth.
These characteristics make it possible to measure dose in the build-up region.
Thermoluminescent Dosimeters
Thermoluminescent dosimeters (TLDs) are available in reusable rods, chips,
and discs. TLDs can be used in vivo and in anthropomorphic phantom studies.
In addition, TLD rods of 1-mm diameter have been used in solid-water
phantoms to measure depth doses, build-up doses, and beam profiles. Newer
TLD readers can sequentially process up to 50 TLD rods without intervention,
making the process more efficient than previously.
Ion chamber measurements can be used to confirm the central axis depth doses.
The small-volume ion chambers used in water phantom dosimetry systems
work well for these measurements. Newer water phantom systems allow
integration of dose at programmed points.
Water phantom alignment with the central axis of the radiation field
(registration) is critically important. If water phantom alignment deviates from
the central axis of the field with depth, the ion chamber may view a different
effective wedge transmission. Therefore, minor angular misalignment may
introduce larger errors in depth dose measurements for wedge fields.
To minimize misalignment errors, measure the depth doses twice, then average
the measurements. Measure once with the collimator at 90° and a second time
with the collimator at 270°.
1. Place the water phantom on a leveling device, such as a 3-point system that
allows adjustment of the plane on which the tank rests.
Note: This device may be part of the cart provided with the water
phantom or it could be a separate device attached to the bottom
of the phantom and resting on the treatment couch or some other
fixed device.
Varian recommends that you perform ion chamber measurements to verify the
effective wedge factor.
Some companies and individuals now offer film densitometry services that
include reading processed film and reporting the dosimetry data in a form
compatible with the treatment planning system requirements. Therefore,
institutions without an on-site film densitometry system can still use this
technique for dose measurement.
Several institutions have made all exposures using the radiation therapy
verification film in its paper envelope. To make the film edge coincident with
the leading edge of the phantom, fold over the paper lip of the envelope above
the film edge. Pierce each film envelope with a pin to evacuate any air in the
envelope during compression into the phantom. This technique delivers good
results.
Extreme care must be taken when processing radiographic film for dynamic
wedge measurements.The low-volume film processors commonly used in
radiation therapy departments are not designed to process large numbers of
films rapidly. The processor temperature rises if a large number of films are fed
through the processor. The rise in temperature changes the film density to dose
response.
In addition, the processor rollers often introduce streak artifacts to the film.
One film is required for each field size and wedge angle.
The beam’s eye view arrangement of the film requires multiple films for each
field size and wedge. For typical fan-line or grid-line tabular data treatment
planning systems, five or six films are needed for each field size and wedge
angle, with the films placed at dmax and at equal depth increments beyond
dmax.
Beam profiles have been measured and compared for the two film
measurement techniques. These comparisons show that the measured profiles
are in agreement at all depths if reasonable care is taken in the film processing.
Two specific problems are associated with the use of film densitometry:
■ Film alignment verification (page 5-10)
■ Film density-to-dose conversion (page 5-11)
To measure the H&D curve, you can use film placed in the phantom in the
same orientation used to expose the Dynamic Wedge fields. That is, if the
wedge films are exposed using the film parallel to the central axis of the field,
then determine the H&D curve using a series of films exposed parallel to the
central axis of the field.
To achieve maximum differentiation of dose from the film densities, adjust the
maximum dose delivered downward so that the maximum film density is still
within the steeply ascending portion of the H&D curve.
Film sensitivity versus depth is dependent on photon energy. The two curves
to the left in Figure 5-1 compare the film densitometer output signal versus
dose at dmax and at 30 cm depth on central axis. Similar measurements were
made at intermediate depths in 5 cm increments. These curves suggest an
increased film sensitivity of approximately 4.2% at 25 cm for 6 MV photons
while showing no increase in film sensitivity for 18 MV photons.
The film sensitivity versus depth effect can be folded into film densitometry
scanning by including a simple dose modifier that corrects the densitometer
reading by the inverse of the sensitivity factor versus depth. This dose modifier
can be represented as:
Variable Description
Evaluation of data for 6 MV suggests a value of 0.0018 cm-1 for the film
sensitivity coefficient (b).
If you ignore the small correction due to energy changes off-axis, this
sensitivity effect is linear with depth. Therefore, you can modify the entire film
density profile at any given depth by this single correction factor. The addition
(and magnitude) of a small correction factor for energy changes off-axis is
reported by Clewlow, Waggener, Feldmeier and Bice, “Film Dosimetry of a
Varian Dynamic Wedge”. (Poster Session S-7, AAPM Annual Meeting,
Calgary, CAN., l992).
Comparison of Arrays
In addition to other alignment checks, you must verify the depth of each linear
detector array relative to the others. Although each detector may have a fixed
position relative to the rest of the array, the entire array may be skewed relative
to water surface when mounted in the water tank. Typically, shims are
provided to adjust the entire array to achieve the desired coincidence with the
water surface.
Because the sensitivity of individual diodes change with dose absorbed by the
diode, you must carefully monitor the relative sensitivity from detector to
detector during dose measurement. Although these sensitivities vary relatively
slowly, you must account for them in the measurements.
Note: When EDW fields are measured, the individual diodes are
exposed to different dose levels. These dose levels vary by
orders of magnitude, depending on the location of the diode. For
example, the diodes near the tip of the wedge receive roughly
twice the dose received by diodes on the central axis while
diodes near the heel of the wedge receive only half of the
central-axis dose.
Diodes outside the geometric limits of the radiation field receive only a small
percentage of the central-axis dose.
Linear detector arrays can measure dynamic wedge dose profiles at any depth
in a phantom. However, you must exercise care in evaluating measurements in
the build-up region.
The ionization chamber array mounts the individual detectors such that the
long axis of the detector is parallel to the central axis of the beam. This
compromises the ability of the detectors to measure dose in the build-up region
where the dose gradient is changing rapidly across the length of the detector.
The linear diode array has an active thickness for each detector of less than l
mm. This allows you to measure dose in the build-up region. However, you
must verify the mechanical placement of each diode. Otherwise, large
differences in reported surface dose and superficial doses are noted from
detector to detector.
The rods have a higher LiF content than previous versions, and so are more
consistent in response.
In combination with the new detectors that can process up to 50 TLDs without
intervention, these rods may be useful in determining build-up doses, depth
doses, and beam profiles at various depths.
Note: They have not yet been proven a viable alternative to other
radiation measurement devices.
6-1
3. From the SELECT TREATMENT menu box, select ENHANCED
D-WEDGE X-RAYS.
4. Press ENTER.
The SELECT ENERGY menu box opens (Figure 6-2) if this is a
high-energy Clinac; otherwise, skip to step 7.
2. Press ENTER.
The SELECT ENERGY menu box opens (Figure 6-8) if this is a high
energy Clinac; otherwise, skip to step 5.
5. Press F4 PARTIAL.
The SELECT MONITOR UNITS menu box adds the OUT OF
ORIGINAL selection.
6. Type the appropriate monitor units required to complete the treatment.
7. Press ENTER.
The cursor moves to the OUT OF ORIGINAL selection.
8. Type the original monitor units.
9. Press ENTER.
The SELECT ENHANCED DWEDGE PARAMETERS box opens
(Figure 6-10).
10. Use the F3 key to select the wedge ORIENTATION (Y1-IN or Y2-OUT).
11. Press ENTER.
Orientation is accepted and cursor moves to COLL Y1.
12. Enter the desired initial position of COLL Y1.
13. Press ENTER.
Position is accepted and cursor moves to COLL Y2.
14. Enter the desired position of COLL Y2.
15. Press ENTER.
Position is accepted and cursor moves to WEDGE ANGLE.
16. Use the numeric keypad to enter the desired WEDGE ANGLE (10°, 15°,
20°, 25°, 30°, 45°, or 60°).
17. Press ENTER.
The WEDGE ANGLE is accepted and the cursor moves to TIME.
The key parameters in EDW are the same parameters that determine the
consistent functioning of the linear accelerator. Therefore, important EDW
parameters are as follows:
■ Output versus field size, depth dose
■ Light field versus radiation field coincidence
■ Light field versus jaw setting
In This Chapter
Topic Page
Dynamic Wedge QA Programs 7-2
Acceptance Testing 7-7
Evolving Technology 7-12
7-1
Dynamic Wedge QA Programs
Assigned Responsibility
A QA program for radiation therapy equipment is very much a team effort, and
the responsibilities of performing various tasks may be divided among the
following:
■ Physicists
■ Dosimetrists
■ Therapists
■ Accelerator engineers
Once you have established a baseline standard, you should develop a protocol
of periodic QA tests to monitor the reference performance values.
Daily Tests
Include the following daily measurements of equipment that seriously affect
patient positioning, and therefore the registration of the radiation field and
target volume:
■ Lasers
■ Optical Distance Indicator (ODI)
■ Patient dose consistency
■ Door interlocks
■ Audiovisual contact
Recommendations
Adhere to the program outlined unless there is demonstrable reason to modify
it. For example, parameters which show large deviations from their baseline
values should be given special attention and checked more frequently.
Alternatively, if careful and extended monitoring demonstrates that a
parameter does not change, or hardly changes at all, then the frequency for
monitoring it could be reduced. Although it is difficult to recommend how long
to monitor a parameter before decreasing the test frequency (the reverse case
is usually obvious). You should assess the QA data over an appreciable history
of equipment performance (for example, 1 year or more), and also assess the
clinical implications of any modification in test frequency. The best guidance
at the present is to design the QA program to be flexible enough to take the
following into account (Ref. 9):
■ Quality
■ Costs
■ Equipment condition
■ Institutional needs
In many clinics, field flatness is measured using a linear detector array which
simultaneously measures fluence at multiple points along a principal axis of
the field. These measurements are then plotted on a display as a beam profile,
and can be saved for comparison with later beam profile measurements. These
devices are available commercially from several companies.
You can use these same devices to measure the integrated beam profile for
EDW. These EDW beam profiles can then be saved for comparison with
profile measurements at a later date. In this manner, you can accumulate and
evaluate a log file of saved profiles in order to detect any long-term shift in the
Enhanced Dynamic Wedge profiles. Use of such a device for field flatness
checks allows the inclusion of beam profile checks for EDW in a simple and
straightforward manner. If you use such a beam profile check device, an
asymmetry detected in the open field should be duplicated in the EDW field
profile as well, because the EDW is the summation of a continuous sequence
of reduced width asymmetric fields. Figure 7-1 illustrates the display of a
wedge profile of two fields using a typical display device.
Initial Measurement
Initial measurement becomes a standard against which future checks are
compared, and should include the following measurements:
■ Measure full-field beam profiles at dmax for the Golden STT of 60°.
■ Measure full-field beam profiles at dmax for the following STT angles: 10°,
15°, 20°, 25°, 30°, 45°, and 60°.
You can then use these to verify intermediate angle interpolations.
■ Measure beam profiles for a series of field widths.
For example, measure profiles for field widths of 5 cm, 10 cm, 15 cm, and
20 cm at dmax, and two to four additional depths for comparison against
profiles generated by a treatment planning computer.
The philosophy adopted here, from discussions with representatives of
treatment planning system vendors, is that the treatment planning systems
are able to generate the required EDW isodose distributions based on a
small subset of measurements, and do not require explicit measurement of
every field width and wedge angle. The required measurements may vary
from vendor-to-vendor, but a subset of measurements as suggested here
should be maintained as a standard against which the computed EDW
beam profiles, central axis depth doses, wedge factors, and other treatment
planning parameters, must compare.
New Modality
In all treatment plans in which EDW fields are applied, Varian suggests that
you verify the individual EDW field by plotting it as a single field incident on
a rectangular phantom. This ensures that the field width, wedge angle and dose
per monitor unit are consistent with the data measured at acceptance. This
provides a valuable visual check that you are applying the EDW data properly
in the treatment planning system.
You should evaluate the influence of nonstandard treatment setup. You can
check this by measuring the ratio of EDW dose to open field dose at a series of
extended and compressed target-to-phantom distances. Consistency of this
ratio with distance across the clinically usable range verifies the simple
relationship of wedge factor versus field size and wedge angle.
Daily Checkout
A daily checkout procedure is in place for every C-Series Clinac. The daily
printout from this checkout is generally stored in a binder for quality
maintenance verification. You should add the EDW fields in current use to the
daily checkout log and automatically exercise them as part of the morning
checkout. You can store the STT calculated versus actual printout as part of the
patient dose verification notes. You can visually verify the initial and final
position of the independent moving jaw and compare it with the printout.
Weekly Checkout
During the weekly output checks when an ionization chamber and phantom are
already in use, you can measure an optional check of the effective wedge factor
for any selected field, generally choosing one or more wedge fields currently
in treatment use.
You can measure the EDW profile at a single depth for one or more fields and
wedge angles, during the monthly check of field flatness, using one of the
devices described previously, such as a linear detector array, film
densitometer, or a series of readings using a movable probe in a phantom. Then
you can superimpose these profiles over the previously measured profiles for
the same field width and wedge angle, as stored in a computer data file. Any
deviation between the profiles indicates a change in the EDW dose delivery
with time, or a difference in the setup and measurement procedure. In order to
eliminate placement errors in the setup of the measurement device, you can
construct a calibration jig which mounts into the accessory tray in a
reproducible manner. These measurements, repeated regularly with time,
constitute a chronological documentation of the performance of the EDW.
Patient Checks
Checks specific to each patient are designed to ensure that the radiation
therapist has set the patient up correctly for using the EDW. Therefore, you can
set fields X and Y, with Y representing the plane in which the EDW defines.
The therapist should carefully verify the proper assignment of Y1-IN or
Y2-OUT to define the direction of jaw travel to define the wedge field. This is
illustrated in the logos on the side of the accelerator head. Similarly, before the
patient is positioned in the room, you can set up and deliver the EDW field to
verify that the wedge is properly defined. After actual treatment, the therapist
should verify that the light field defines only a narrow strip corresponding to
the tip of the wedge. This should be in agreement with the EDW icon drawn
on the treatment control monitor.
All involved in the treatment should be aware that the EDW is not a four-way
wedge, as are the type III accessory wedges. You can achieve orthogonal
wedge directions by rotating the collimator 90°.
Evolving Technology
This appendix shows the EDW fluence profiles. These Segmented Treatment
Tables (STTs) are referred to as the Golden STTs because all other wedges
(both field size and wedge angle) are formed from these reference STTs.
A-1
A-2 Enhanced Dynamic Wedge Implementation Guide
EDW Fluence Profiles (Golden STTs) A-3
A-4 Enhanced Dynamic Wedge Implementation Guide
EDW Fluence Profiles (Golden STTs) A-5
A-6 Enhanced Dynamic Wedge Implementation Guide
EDW Fluence Profiles (Golden STTs) A-7
A-8 Enhanced Dynamic Wedge Implementation Guide
Appendix B STT Computations
DATE.......................: 04/24/1997
TIME.......................: 10:00:57
D Y N A M I C B E A M D E L I V E R Y L O G F I L E
** T R E A T M E N T S E T U P **
ENERGY : 6 X
MU : 300
ORIENTATION : Y1-IN
ACCESSORY : NO ACCESSORY
B-1
** D Y N A M I C B E A M S T A T I S T I C S **
-- STT --
To derive the dose and position values for instances 2, 5, and 18 (bolded in the
proceeding table), use their Y1 positions of 10.00 cm, 7.70 cm, and 2.20 cm.
Apply these weights to derive the Golden STT for the effective wedge angle
(45°).
Dose Position
0.732543 -10.00 cm
0.787736 -8.00 cm
0.819441 -7.00 cm
1.282903 2.00 cm
1.361538 3.00 cm
1.447478 4.00 cm
1.541369 5.00 cm
Similarly, we derive interpolated dose values for the other 3 sample points in
our computation where Y1 = 10.00 cm, 7.70 cm, and -2.20 cm (the 10.00 cm
value does not require interpolation).
Y1 Dose
10.00 cm 0.732543
7.70 cm 0.797247
-2.20 cm 1.29863
-4.50 cm 1.494424
10.00 cm 147.06 MU
7.70 cm 160.04 MU
-2.20 cm 260.70 MU
-4.50 cm 300.00 MU
References
Within this guide, there are specified papers and references that correspond to
these numbers:
C-1
7. Klein E, Low D, Durbin C, Meigooni A, Purdy J
Dosimetry for Clinical Implementation of Dynamic Wedge on a
CL-2100C
Med Phys 1993 May-Jun
8. Boyer A, Waldron T, Wells N
Calculation of Dynamically-Wedged Isodose Distributions from
Segmented Treatment Tables and Open-Field Measurements
Med Phys 1994 May-Jun
9. AAPM
Task Group 40 Report; Comprehensive QA for Radiation Oncology
Med Phys 1994; 24:587-8
Beavis AW.
Implementation of Enhanced Dynamic Wedge Into the Multidata DSS
Radiotherapy Treatment Planning System.
Med Dosim 1997 Fall; 22(3):219-25
Earley L.
Larger Field Sizes: An Advantage of the Dynamic Wedge.
Med Dosim 1997 Fall; 22(3):193-5
Edlund TL.
Treatment Planning of Oblique Wedge Fields Comparing Enhanced
Dynamic Wedge and Standard 60 Degree Wedge for Parotid Type
Treatments.
Med Dosim 1997 Fall; 22(3):197-9
Karlsson M.
Implementation of Varian's EDW 5.2 On a Clinac 2300C/D for Use With
Helax TMS 3.1 Dose Planning System.
Med Dosim 1997 Fall; 22(3):215-8
Klein EE.
Treatment Planning for Enhanced Dynamic Wedge With the CMS
Focus/Modulex Treatment Planning System.
Med Dosim 1997 Fall; 22(3):213-4
Lamb A, Blake S.
Investigation and Modelling of the Surface Dose From Linear Accelerator
Produced 6 and 10 MV Photon Beams.
Phys Med Biol 1998 May; 43(5):1133-46
Leavitt DD
New Application of Enhanced Dynamic Wedge for Tangent Breast
Irradiation.
Med Dosim 1997 Fall; 22(3):247-51
Leavitt DD, Lee WL, Gaffney DK, Moeller JH, O'Rear JH.
Dosimetric Parameters of Enhanced Dynamic Wedge for Treatment
Planning and Verification.
Med Dosim 1997 Fall; 22(3):177-83
Li Z, Klein EE.
Surface and Peripheral Doses of Dynamic and Physical Wedges.
Int J Radiat Oncol Biol Phys 1997 Mar 1; 37(4):921-5
Sidhu NP.
Interfacing a Linear Diode Array to a Conventional Water Scanner for the
Measurement of Dynamic Dose Distributions and Comparison With a
Linear Ion Chamber Array.
Med Dosim 1999 Spring; 24(1):57-60
Warlick WB, O'Rear JH, Earley L, Moeller JH, Gaffney DK, Leavitt DD.
Dose to the Contralateral Breast: a Comparison of Two Techniques Using
the Enhanced Dynamic Wedge Versus a Standard Wedge.
Med Dosim 1997 Fall; 22(3):185-91
Weides CD, Mok EC, Chang WC, Findley DO, Shostak CA.
Evaluating the Dose to the Contralateral Breast When Using a Dynamic
Wedge Versus a Regular Wedge.
Med Dosim 1995 Winter; 20(4):287-93
Zhu TC, Ding L, Liu CR, Palta JR, Simon WE, Shi J.
Performance Evaluation of a Diode Array for Enhanced Dynamic Wedge
Dosimetry.
Med Phys 1997 Jul; 24(7):1173-80
D-1
default Standby data the computer uses when a parameter (or
program) is not specified.
monitor unit (MU) A unit of radiation exposure. A table for the conversion of
monitor units into units of absorbed dose (gray or rad) can
be generated by a dose calibration of the machine by a
qualified physicist.
Glossary D-3
override To go around an automatic control system (like the
interlock system) intentionally. To bridge a functional stage
of the control system.
Target-Axis (TAD) The distance measured along the central axis from
Distance the center of the front surface of the target to the isocenter.
Target-Skin (TSD) The distance measured along the central axis from
Distance the center of the front surface of the target to the surface of
the irradiated object.
Glossary D-5
Index
A data
generating sets, 4-26
acceptance testing, 7-7
acquiring dose profiles, 4-25 handling techniques, 4-2
alternative methods, 4-26 measuring, 5-2
arrays date stamp, 3-27
comparison, 5-14 defining
ion chamber, 5-14 cold window, 3-20
linear detector, 5-14 dose rate ceiling, 3-5
relative depth, 5-15 dynalog files, 3-23
thermoluminescent, 5-18 Enhanced Dynamic Wedge (EDW), 1-1, 2-4
auto field sequency (AFS), 1-6 field size, 5-1
Golden STTs, 3-14
B hot window, 3-20
physical wedge, 2-2
baseline standards, 7-3
beam sample STT, 3-9
profile (figure), 7-6 Segmented Treatment Tables (STTs), 3-2,
profile measurements, 5-6 3-7
profiles, 4-16 wedge angle, 2-2, 2-6
beam’s eye view collimator graphic, 3-5 delivering
dose, 1-3
STT, 3-19
C total dose, 3-27
calibration techniques, 5-17 densitometry
capabilities, EDW, 1-4 film, 5-7
cold window defined, 3-20
collimator measurements, 7-6
beam’s eye view graphic, 3-5 depth dose, 4-21
field size check, 5-1 (figure), 4-22
comparing EDW, 4-21
arrays, 5-14 measuring, 5-4
film techniques, 5-10 open field, 4-21
computation, 3-19 physical wedge, 4-21
effective wedge angles, 3-15 wedge field, 4-21
sample STTs, B-3 diodes, 5-3
STTs, B-1 distribution, wedge, 4-3
continuous dose delivery, 3-2 dose
converting film density-to-dose, 5-11 acquiring profiles, 4-25
continuous delivery, 3-2, 3-11
correction factor, 5-14
D delivery, 1-3
daily depth, 4-21
checkout, 7-10
fraction, 1-3
tests, 7-3
modifier, 5-13
peripheral, 4-24
Index-1
dose (continued) Enhanced Dynamic Wedge (continued)
position standard deviation, 3-28 profiles, 4-28 to 4-31
position standard deviation formula, 3-22 sample STT, 3-8
profile, 3-2 surface dose, 4-23
rate treatment setup, 6-1
ceiling defined, 3-5 estimating effective EDW factor, 4-20
progression (figure), 3-3 evaluating measurements in build-up region,
versus jaw position, 3-6 5-17
evolving technology, 7-12
standard deviation, 3-27
standard deviation formula, 3-22
surface, 4-23 F
total delivered, 3-27 field
tracking accuracy, 3-21 open phase, 3-2
verification, 3-6 size check, 5-1
versus jaw position, 1-7, 3-2 size defined, 5-1
(figure), 3-4 size width, 1-5
STT, 3-10 film
densitometry, 5-7
dosimetry, film cassettes, 5-8
DPSN interlock, 1-7, 3-20, 3-29 densitometry, problems, 5-10
dynalog files, 1-5, 1-7 density-to-dose conversion, 5-11
defined, 3-23 dosimetry cassettes, 5-8
location, 3-29 radiographic, 5-8
sample, 3-24, B-1 sensitivity
dynamic beam statistics, 3-27 coefficient, 5-13
dynamic wedge versus depth, 5-12
(figure), 2-5 versus depth (figure), 5-12
quality assurance, 7-2 techniques compared, 5-10
quality assurance program, 7-5 verifying alignment, 5-10
final verification, 7-12
E first clinical implementation, 2-2
fluence profiles, 3-14
effective wedge factor, 4-17 formula
Enhanced Dynamic Wedge (EDW) dose modifier, 5-13
additional features, 1-6
dose standard deviation, 3-22
capabilities, 1-4
dose weighted position standard deviation,
compared to physical wedge, 4-3
3-22
data in treatment planning, 4-25
standard deviation variables (table), 3-22
defined, 1-1, 2-4
fraction, dose, 1-3
depth dose, 4-21
dose and jaw motion, 3-2
estimating effective factor, 4-20 G
feature, 2-2 generating
feature comparison to dynamic wedge, 1-5 data sets, 4-26
fluence profiles, A-1 STTs, 3-12
Golden STTs, A-1 STTs (figure), 3-13
key difference to dynamic wedge, 2-6 Golden STTs
(table), A-1
key parameters, 7-1
defined, 3-14
Index-2
H L
H&D curve, 5-11 linear detector arrays, 5-14
historical perspective, 2-1
hot window defined, 3-20
M
measurement
I densitometry, 7-6
ICRU report, 2-4 devices, 5-3
IEC report, 2-4 diodes, 5-3
implementation, 2-1
implementation, first clinical, 2-2 ionization chamber, 5-3
initial measurement, 7-7 thermoluminescent dosimeters (TLDs),
interlock 5-3
DPSN, 1-7, 3-20, 3-29 verification film, 5-3
IPSN, 3-20, 3-29 initial, 7-7
ion chamber array, 5-14 single probe, 7-6
ionization chamber, 5-3 techniques, 7-3
IPSN interlock, 3-20, 3-29
isodose measuring
curves, 4-3 to 4-15 data, 5-2
profile, 3-2 H&D curve, 5-11
minimizing misalignment errors, 5-5
MLC, 1-6
J monitoring relative sensitivity, 5-16
jaw monthly
motion, 3-2 checkout, 7-11
motion model, 3-11 tests, 7-4
position
tracking accuracy, 3-21 N
verification, 3-6 new modality, 7-9
position versus dose, 1-7, 3-2 normalize, 3-19
(figure), 3-4
rate, 3-6 O
STT, 3-10 open field
speed depth dose, 4-21
modulation, 3-6 fluence weights, 3-17
progression (figure), 3-4 phase, 3-2
sweep, 1-3 orientation
action (figure), 1-2 Y1-IN, 3-1
phase, 3-3 Y2-OUT, 3-1
velocity, 3-6
P
K partial treatment, 1-6
key differences partial treatment setup, 6-8
(table), 2-6 patient checks, 7-11
dynamic versus EDW, 2-6 pendant, confirm wedge orientation, 1-5
peripheral dose, 4-24
key parameters, EDW, 7-1
Index-3
phase Segmented Treatment Tables (STTs), 1-5, 2-1
jaw sweep, 3-2 computations, B-1
open field, 3-2 defined, 3-2, 3-7
physical wedge, 4-19 delivery, 3-19
(figure), 2-3 dose versus jaw position, 3-10
compared to EDW, 4-3 EDW, sample (figure), 3-8
defined, 2-2 generation, 3-12
depth dose, 4-21 (figure), 3-13
factor variations, 4-19 Step 1 - fluence profiles, 3-14
surface dose, 4-23 Step 2 - computation of effective wedge
portal imaging, 1-5 angles, 3-15
primary intensity profiles, 4-27 Step 3 - truncation process, 3-18
processing radiographic film, 5-8
profile Step 4 - normalize, 3-19
acquiring dose, 4-25 Step 5 - compute, 3-19
beam, 4-16 Golden STTs
beam (figure), 7-6 (table), A-1
beam measurements, 5-6 defined, 3-14
dose, 3-2 sample computations, B-3
EDW, 4-28 to 4-31 using, 4-27
EDW fluence, A-1 single probe measurements, 7-6
fluence, 3-14 surface dose, 4-23
EDW, 4-23
Golden STTs, A-1
physical wedge, 4-23
primary intensity, 4-27
sweep phase, jaw, 3-3
R T
radiographic film, 5-8 tabulated data sets, 4-25
recommendations, 7-4 thermoluminescent
redundant position readouts, 1-7 arrays, 5-18
references, C-1
related publications, vi dosimeters (TLDs), 5-3
reports time stamp, 3-27
ICRU, 2-4 total dose delivered, 3-27
IEC, 2-4 tracking accuracy statistics, 3-21
treatment
research, 2-1 EDW setup, 6-1
routine machine checks, 7-10
nonstandard setup, 7-9
partial setup, 6-8
S planning, 4-25, 5-2
sample planning checks, 7-9
computation of STTs, B-3 setup, 3-27
dynalog file, B-1 specific checks, 7-11
STT, 3-8 time, 3-6
segment boundary samples, 3-29 truncation process, 3-18
truncation process (figure), 3-18
Index-4
U Y
using STTs, 4-27 Y1-IN orientation, 3-1
Y2-OUT orientation, 3-1
V
verification, final, 7-12
verifying
field size definitions, 5-1
film alignment, 5-10
relative depth of arrays, 5-16
water level in phantom, 5-4
visual cues, v
W
water phantom
aligning, 5-4
aligning tips, 5-5
verifying water level, 5-4
wedge
angle, 1-5
computing effective, 3-15
defined, 2-2, 2-6
distribution, 4-3
dynamic
(figure), 2-5
quality assurance, 7-2
quality assurance programs, 7-5
effective factor, 4-17
factor (figure), 4-18
factor measurements, 5-6
field depth dose, 4-21
fluence weights, 3-17
generated program, 4-26
key differences, dynamic versus EDW, 2-6
orientation, 3-1
orientation confirm through pendant, 1-5
physical, 4-19
(figure), 2-3
defined, 2-2
depth dose, 4-21
factor variations, 4-19
surface dose, 4-23
weekly checkout, 7-10
Index-5